Medical News

RSS

Transgenomic introduces Nuclear Mitome Test for diagnosis of mitochondrial disorders

Transgenomic, Inc. today announced the launch of the Nuclear Mitome Test, a genetic test to aid physicians in the diagnosis of mitochondrial disorders.

17 Jun 2011

USPTO issues patent for Predictive Biosciences' multiple biomarker assay

Predictive Biosciences, a provider of novel molecular diagnostic tests, announced that on June 7, 2011 the U.S. Patent and Trademark Office issued Patent Number 7,955,822 for "Detection of Nucleic Acids and Proteins".

17 Jun 2011

Roundup: Few states raise taxes to ease budgets; Ala. Gov. signs abortion law; Texas House advances bill to turn Medicaid, Medicare into block grants

As 2011 began, the budget situation in state capitals looked more dire than just about anybody could remember. ... With Medicaid, the states had their hands tied. The new federal health care law prohibits states from cutting eligibility or making it harder for people to apply for coverage. So states had to find other ways to control costs. Idaho reduced the amount paid to hospitals and doctors to treat Medicaid patients, an idea that some 30 governors proposed this year.

17 Jun 2011

New Australian drug shows positive response in patients with multiple myeloma blood cancer

Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today announced it would double patient recruitment in its Phase II trial for a breakthrough antibody treatment for terminal blood cancer.

16 Jun 2011

Tunstall named HealthInvestors Telehealthcare provider of the year

Against stiff competition, Tunstall Healthcare, the world's leading provider of telehealthcare solutions has been named HealthInvestor's telehealth/telecare provider of the year at its 2011 London awards ceremony.

16 Jun 2011

Austria "FIT for Research"

Experience research with state-of-the-art media technology: at St. Poelten University of Applied Sciences, Austria. On the evening of 23 September, the University will merge research, art and lifestyle under the motto "FIT for research". The unique combination is Austria's contribution to European Researchers' Night 2011.

16 Jun 2011

CEVEC and Catalent Pharma Solutions offer joint cell line development service

CEVEC Pharmaceuticals, the German developer of a novel, market leading human protein expression system derived from amniocytes, and Catalent Pharma Solutions, a leading global drug development and delivery solutions provider, announced today a joint commercial cell line development service for pharma and biotech customers worldwide. The offering combines the benefits of CEVEC’s human cell line, CAP-Technology, with Catalent’s unique GPEx® (Gene Product Expression) Technology to generate high expressing stable human cell lines in a much shorter timeframe than traditional methods.

16 Jun 2011

Hopkins research suggests that blood vessels and support cells may be real targets of treatment for diabetic nerve damage

Blood vessels and supporting cells appear to be pivotal partners in repairing nerves ravaged by diabetic neuropathy, and nurturing their partnership with nerve cells might make the difference between success and failure in experimental efforts to regrow damaged nerves, Johns Hopkins researchers report in a new study.

16 Jun 2011

Adaptimmune melanoma trial opening

Adaptimmune announced today that it has opened a Phase I/II, two cohort, open label clinical trial in metastatic melanoma at Washington University, St. Louis, Missouri.

16 Jun 2011

Low testosterone linked to varicoceles

As many as 15 percent of men have varicoceles, masses of enlarged and dilated veins in the testicles. There is new evidence that varicoceles, long known to be a cause of male infertility, interfere with the production of testosterone -- a crucial hormone to maintaining men's health. There is good news too: Microsurgery can increase testosterone levels in these men. Results of new research by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center are in a recent edition of BJU International.

16 Jun 2011

Lumosity announces $32.5M Series C financing round

Lumosity announced today it has raised $32.5 million in Series C financing. Lumosity leverages cutting-edge neuroscience to create games and exercises that improve core cognitive abilities and enable users to remember more, think faster and perform better at work and school.

16 Jun 2011

Boosting immune response could increase inflammation

People often talk about "boosting" their immunity to prevent and fight colds. Nutritional supplements, cold remedies and fortified foods claim to stave off colds by augmenting the immune system.

16 Jun 2011

Benefitfocus unveils Medical Loss Ratio Rebate App for insurance companies

Benefitfocus today unveiled its Medical Loss Ratio Rebate App, which helps health insurance companies calculate premium contributions and manage rebates as they adjust to new medical loss ratio (MLR) requirements.

16 Jun 2011

Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis

Aradigm Corporation today announced positive top line data from its recently concluded Phase 2b study (Once-Daily Respiratory Bronchiectasis Inhalation Treatment - ORBIT-1) with Aradigm's ciprofloxacin for inhalation (CFI, ARD-3100, LipoquinTM) in patients with non-cystic fibrosis bronchiectasis (BE).

16 Jun 2011

Ankota introduces TherapEZ web-based, mobile tablet-based solution for home health therapy agencies

Ankota, the developer of the first Healthcare Delivery Management (HDM) solutions, introduced today its TherapEZ software as a solution for streamlining many of the operational issues faced by home health therapy agencies as they seek to provide services for patients at home and to coordinate care with home health agencies.

16 Jun 2011

First Edition: June 16, 2011

In today's headlines, reports about the prospect for Medicaid cutbacks in an emerging bipartisan budget deal, as well as how a report from a Medicare advisory panel may bolster Medicare options currently on the table.

16 Jun 2011

Enrollment complete in NeurogesX NGX-1998 Phase 2 clinical study for postherpetic neuralgia

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the completion of patient enrollment in its Phase 2 clinical study of NGX-1998, a topical liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).

16 Jun 2011

Study finds life expectacy in large portions of U.S. are stagnating or declining

"Large swaths of the United States are showing decreasing or stagnating life expectancy even as the nation's overall longevity trend has continued upwards, according to a county-by-county study of life expectancy over two decades," researchers at the Institute of Health Metrics and Evaluation (IHME) at the University of Washington note in the journal Population Health Metrics, the Washington Post reports (Brown, 6/15).

16 Jun 2011

Positive results from Cubist CXA-201 and CB-183,315 Phase 2 studies for complicated intra-abdominal infections

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced positive top-line results from the recently completed Phase 2 studies of its CXA-201 and CB-183,315 antibiotic pipeline candidates. CXA-201 was studied for the treatment of complicated intra-abdominal infections (cIAI) in adults.

16 Jun 2011

CBO portends 'heavy lifting' to avert Medicare doc pay reduction

The report offers cost estimates for a range of approaches that would head off a 29.4 percent reduction in Medicare physician payments scheduled to kick in Jan. 1, 2012. Meanwhile, in other news, a plan to curb the overuse of costly medical imaging demonstrates the difficulties posed by attempting even small changes in the health insurance program for seniors.

16 Jun 2011

Medical News

Transgenomic introduces Nuclear Mitome Test for diagnosis of mitochondrial disorders

USPTO issues patent for Predictive Biosciences' multiple biomarker assay

Roundup: Few states raise taxes to ease budgets; Ala. Gov. signs abortion law; Texas House advances bill to turn Medicaid, Medicare into block grants

New Australian drug shows positive response in patients with multiple myeloma blood cancer

Tunstall named HealthInvestors Telehealthcare provider of the year

Austria "FIT for Research"

CEVEC and Catalent Pharma Solutions offer joint cell line development service

Hopkins research suggests that blood vessels and support cells may be real targets of treatment for diabetic nerve damage

Adaptimmune melanoma trial opening

Low testosterone linked to varicoceles

Lumosity announces $32.5M Series C financing round

Boosting immune response could increase inflammation

Benefitfocus unveils Medical Loss Ratio Rebate App for insurance companies

Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis

Ankota introduces TherapEZ web-based, mobile tablet-based solution for home health therapy agencies

First Edition: June 16, 2011

Enrollment complete in NeurogesX NGX-1998 Phase 2 clinical study for postherpetic neuralgia

Study finds life expectacy in large portions of U.S. are stagnating or declining

Positive results from Cubist CXA-201 and CB-183,315 Phase 2 studies for complicated intra-abdominal infections

CBO portends 'heavy lifting' to avert Medicare doc pay reduction

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News